ArticleArchives of medical science : AMS2026
A real-world pharmacovigilance analysis of cardiac, endocrine, and neurological adverse events associated with cabergoline: a disproportionality study.
Yu-Zhen Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.